157 related articles for article (PubMed ID: 25387409)
1. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
[No Abstract] [Full Text] [Related]
2. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
[TBL] [Abstract][Full Text] [Related]
3. Correlation of WT1 expression with the burden of total and residual leukemic blasts in bone marrow samples of acute myeloid leukemia patients.
Alonso-Dominguez JM; Tenorio M; Velasco D; Abalo L; Lozano S; Villarrubia J; López-Jimenez J; Grande S; Ayala R
Cancer Genet; 2012 Apr; 205(4):190-1. PubMed ID: 22559982
[No Abstract] [Full Text] [Related]
4. Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
De Marchi F; Candoni A; Zannier ME; Haley L; Lau BW; Fanin R
Am J Hematol; 2017 May; 92(5):E72-E74. PubMed ID: 28211167
[No Abstract] [Full Text] [Related]
5. Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML.
Nomdedéu JF; Hoyos M; Carricondo M; Bussaglia E; Estivill C; Esteve J; Tormo M; Duarte R; Salamero O; de Llano MP; García A; Bargay J; Heras I; Martí-Tutusaus JM; Llorente A; Ribera JM; Gallardo D; Aventin A; Brunet S; Sierra J;
Leukemia; 2013 Nov; 27(11):2157-64. PubMed ID: 23584566
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of the alternative Wilms tumor gene overexpression-hypermethylation signature in acute myeloid leukemia.
El Bordiny M; Al-Ghandour A; Abo Elwafa RA; Fayed O
Clin Transl Oncol; 2019 Jul; 21(7):864-873. PubMed ID: 30506133
[TBL] [Abstract][Full Text] [Related]
8. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
[TBL] [Abstract][Full Text] [Related]
9. WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia.
Sakamoto Y; Mariya Y; Sasaki S; Teshiromori R; Oshikiri T; Segawa M; Ogura K; Akagi T; Kubo K; Kaimori M; Funato T
Tohoku J Exp Med; 2009 Oct; 219(2):169-76. PubMed ID: 19776535
[TBL] [Abstract][Full Text] [Related]
10. Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia.
Marani C; Clavio M; Grasso R; Colombo N; Guolo F; Kunkl A; Ballerini F; Giannoni L; Ghiggi C; Fugazza G; Ravetti JL; Gobbi M; Miglino M
Leuk Res; 2013 Dec; 37(12):1606-11. PubMed ID: 23891447
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.
de Leeuw DC; Verhagen HJ; Denkers F; Kavelaars FG; Valk PJ; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Leukemia; 2016 Mar; 30(3):742-6. PubMed ID: 26108690
[No Abstract] [Full Text] [Related]
13. The association of level of reduction of Wilms' tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients.
Shibasaki Y; Seki Y; Tanaka T; Miyakoshi S; Fuse K; Kozakai T; Kobayashi H; Ushiki T; Abe T; Yano T; Moriyama M; Kuroha T; Isahai N; Takizawa J; Narita M; Koyama S; Furukawa T; Sone H; Masuko M
Leuk Res; 2015 Jun; 39(6):667-71. PubMed ID: 25890432
[TBL] [Abstract][Full Text] [Related]
14. Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference values.
Løvvik Juul-Dam K; Guldborg Nyvold C; Vålerhaugen H; Zeller B; Lausen B; Hasle H; Beier Ommen H
Pediatr Blood Cancer; 2019 Jun; 66(6):e27671. PubMed ID: 30900388
[TBL] [Abstract][Full Text] [Related]
15. [Expression of WT1 Gene in Bone Marrow of Patients with Acute Myeloid Leukemia and Its Influence on Prognosis].
Zheng YT; Li BX; Sun YJ; Yu CL; Sun QY; Qiao JH; Hu KX; Zuo HL; Dong Z; Ai HS; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):649-54. PubMed ID: 27342485
[TBL] [Abstract][Full Text] [Related]
16. Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia.
Andersson C; Li X; Lorenz F; Golovleva I; Wahlin A; Li A
Diagn Mol Pathol; 2012 Dec; 21(4):225-33. PubMed ID: 23111196
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
[TBL] [Abstract][Full Text] [Related]
18. Assessment of WT1 Expression as a Marker of Treatment Outcome in Karyotype Normal Acute Myeloid Leukemia Patients in Pakistan.
Ahmed ZA; Shaikh MS; Moatter T
J Coll Physicians Surg Pak; 2016 May; 26(5):441-2. PubMed ID: 27225156
[TBL] [Abstract][Full Text] [Related]
19. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2013 Aug; 33(8):3335-40. PubMed ID: 23898100
[TBL] [Abstract][Full Text] [Related]
20. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.
Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH
Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]